EP0274345B1 - Dividable capsule - Google Patents
Dividable capsule Download PDFInfo
- Publication number
- EP0274345B1 EP0274345B1 EP87810649A EP87810649A EP0274345B1 EP 0274345 B1 EP0274345 B1 EP 0274345B1 EP 87810649 A EP87810649 A EP 87810649A EP 87810649 A EP87810649 A EP 87810649A EP 0274345 B1 EP0274345 B1 EP 0274345B1
- Authority
- EP
- European Patent Office
- Prior art keywords
- capsule
- divisible
- dosage units
- capsule according
- units
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Revoked
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
- A61J3/07—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of capsules or similar small containers for oral use
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
- A61J3/07—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of capsules or similar small containers for oral use
- A61J3/071—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of capsules or similar small containers for oral use into the form of telescopically engaged two-piece capsules
Definitions
- the present invention is directed to capsules which are divisible by the user into accurate individual dosage units.
- a patient it is desirable for a patient to be able to administer medicine to him or herself in varying dosages.
- a patient may begin medication in larger dosages, and then proceed to smaller dosages, or vice versa, as treatment progresses.
- different dosages may be desirable for different individuals.
- Some drugs require monitoring of drug blood level until the patient is stabilized and divisible dosage forms provide a non-complicated procedure for achieving this.
- capsules in varying sizes While providing capsules in varying sizes is possible, it may not be feasible to predict in advance how many capsules in which sizes are necessary for a given patient. In addition, production of capsules in varying sizes complicates the manufacturing process and adds to the patients' cost in the event the dosage must be changed.
- divisible capsules are desirable since they may be used to separate drugs which are interactive, for example, propoxyphene in its hydrochloride or other suitable salt form and aspirin or sodium meclofenamate and codeine sulphate. Further, they may be arranged so as to formulate a portion of the capsule to be slow releasing while the other portion furnishes drug in a readily available fast-dissolving form, or to include two or three sections all having modified release properties which will afford optimal drug blood levels or by attaching a separate section which has enteric properties.
- EP-A-0 141 397 discloses a divisible capsule which when undivided is in the shape of a conventional capsule.
- the capsule is divisible along a plane running along the entire length of the capsule and bisecting it by twisting the two "half capsule” parts away from each other.
- the result is two capsule units, each of which has a cross-section in the shape of a semi-circle and a flat, planar surface which previously had been connected to the flat, planar surface of the other capsule unit.
- US-A-1510260 discloses a package containing a plurality of gelatinuous hollow bodies, each having a rounded, closed end and, an open end, the hollow bodies being nested in series, with the last body of the series being sealed by a closure member.
- GB-A-2,148,841 discloses divisible capsules which are formed with integrally molded connection elements.
- a number of capsule bodies would be manufactured with integrally molded webs between and connecting adjacent capsule bodies, while the capsule caps might also have such integrally molded connection elements.
- a capsule which is divisible by the user into accurate individual dosage units, comprising at least two dosage units, each of which is capable of holding a desired medicinal preparation, and is of substantially cylindrical shape, the dosage units being detachably joined to one another in such a manner that their respective longitudinal axes are approximately co-linear in the assembled capsule, wherein each said individual dosage unit is sealed by a closure.
- a divisible capsule which is comprised of first and second dosage units, each of which is cylindrical about an axis along the major part of its length, and wherein the capsule units are detachable joined to each other in such manner that the longitudinal axes of the respective capsule units are approximately co-linear.
- the dosage units of the divisible capsule are terminal dosage units each of which has a first closed, preferably rounded end, and a second open end being sealed by a closure, and wherein each of the closures abuts the neighbouring dosage unit to which it is detachably joined in the assembled capsule.
- the divisible capsule may further include at least one intermediate dosage units having two open ends both of which are sealed by a closure and wherein each of the closures of the intermediate dosage unit abuts the closure of the neighbouring dosage unit, to which the intermediate dosage unit is detachably joined in the assembled capsule.
- cylindrical encompasses tubular shapes having circular cross-sections such as elliptical cylinders. While a circular cylindrical shape is preferred, substantially cylindrical capsules of other shapes are contemplated. Thus, those having octagonal, hexagonal, square, or other geometrical cross sections are operable. Capsule shapes which resemble tablets (i.e., which are not significantly elongated) could also be used.
- the capsule units are detachably joined to each other by various expedients including connection by adhesive, an annular band, and mechanical locking means.
- Such an annular band may further comprise constructive regions and/or perforations.
- divisible capsule 2 is shown. It is comprised of capsule units 4 and 6, each of which is filled with a desired medicinal preparation 8.
- each of the capsule units 4 and 6 is comprised of a shell which is cylindrical about an axis over the major portion of its length and rounded at one end.
- the capsule units are juxtaposed longitudinally so that the cylindrical axes of the respective capsule units are approximately co-linear and are detachably secured to each other in this configuration.
- band 10 is provided which is a thin plastic band of the type sometimes used to secure the bodies and caps of conventional capsules together.
- the band is perforated at 13 to permit easy separation of the capsule units from each other.
- the band is an annular sleeve 12 having constrictive segments 14 to provide a friction fit.
- the constrictive segments may be dimples or other raised areas.
- the capsules depicted in Figures 1 and 2 may be taken as shown to provide a full dose or may be separated from each other by the user to provide a convenient half dose.
- the capsules shown in the illustrative embodiments are bisectable capsules which provide accurate half doses, if desired, the capsules may be dividable in some other proportion, for example, one-third to two-thirds. Conceivably, the capsule could be a series of segments held together as shown and used for dose titration purposes.
- a method of making the divisible capsules is shown in Figures 5-7.
- a method of making capsules according to the present invention comprises the steps of: filling at least two substantially cylindrical dosage units with a desired medicinal preparation; sealing each of the dosage units with a closure; and detachably joining the dosage units to each other in such a manner that their respective longitudinal axes are approximately co-linear.
- capsule units 4 and 6 are shown. These may be the caps of conventional capsules, typically comprised of a capsule body and capsule cap, and are frequently made of hard gelatin, but may be made of other suitable material. Instead of the capsule caps, capsule bodies may be used, and as these are longer, it may be desirable to cut them, for example, to two-thirds length.
- the capsule units are filled with a desired medicinal preparation.
- a desired medicinal preparation may be in the form of pellets, granules, or viscous or liquid substance.
- the filling step may be performed with the automatic filling machines customarily used to fill conventional capsules.
- the capsule units would be filled to within a small distance of the top, for example about one-sixteenth of an inch, and as shown in Figure 7, a thin layer 9 of adhesive paste would be applied to the top to seal in the medicinal preparation.
- the capsule units would then be turned inwardly towards each other with the adhesive paste layers abutting each other, and adhesive paste would be applied to the inside and outside of the joint area, after which the joint would be air dried.
- the adhesive paste used as described above could be a polymer solution as follows:
- the capsule units are as shown in Figure 8, and each comprises a body portion (22, 24) and a cap (26, 28), wherein the cap (26, 28 ) has a flat surface and is fitted to snugly fit over the body portion (22, 24).
- the caps (26, 28) are bonded to each other with adhesive paste 30 as shown in Figure 3 or by a separately molded section which is sealed to the capsule section by means of solvent welding.
- a band 31 having constrictive segments 32 is also added. It is possible that in this embodiment one may dispense with the adhesive paste.
- FIGS 9-16 illustrate further embodiments of the invention wherein locking mechanical means is used to join the two capsule units.
- capsule units 40 and 44 are shown filled with medicinal preparation 46.
- Capsule unit 40 is enclosed by cap 42 while capsule unit 44 is closed by adhesive layer 48 or by a friction fit with or without use of a solvent seal.
- Locking part 50 is used to secure the two capsule units together.
- Locking part 50 has open cylindrical recess 53 and annular groove 55.
- Cap 42 of capsule unit 40 is held snugly in annular groove 55.
- the molded piece may be made of the same material as the capsule units and the divisible capsule as assembled is shown in Figure 10.
- capsule unit 51 is closed by cap 52 and intermediate molded piece 56 serves both as a closure for capsule unit 54 and as a connecting means to secure the two capsule units together.
- Molded piece 56 has open cylindrical recesses 57 and 59, which are separated by flat surface 61.
- Recess 57 is sized so as to snugly receive cap 52 of capsule unit 51 while recess 59 is sized so as to receive capsule unit 54 in such manner that flat surface 61 acts as a closure for the medicinal preparation in capsule unit 54.
- the recesses 57 and 59 may have friction fit features such as dimples to enhance the tightness with which the capsule units are held together.
- the assembled capsule units are shown in Figure 12.
- FIG. 13 A further embodiment to the invention is shown in Figure 13 wherein cylindrical capsule unit parts 60 and 64 are shown. Each of these capsule unit parts is filled with a desired medicinal preparation, and the capsule unit parts are sealed with rounded or flat caps 62 and 66 respectively.
- the other end of capsule unit 60 is provided with a female member 68 which may for example be a cylindrical recess, while capsule unit 64 is provided with a male member 70, which for example may be a cylindrical projection resembling a spike.
- the male and female members are sized so as to provide a tight friction fit, which may be enhanced by the provision of additional locking means such as one or more dimples on one of the members and a corresponding number of detents on the other of the members.
- Capsule unit parts 60 and 64 may be made of hard gelatin or other known material used for capsule bodies. The assembled divisible capsule is shown at Figure 14.
- Figures 15 and 16 illustrate a divisible capsule which is similar to that shown in Figures 13 and 14, except that the locking recess and projection are larger in diameter.
- Figure 17 illustrates a divisible capsule which is comprised of three units instead of two.
- the units are body 100/cap 107, body 102/cap 108, and body 101/cap 110.
- cap 110 has a cylindrical recess 106 therein, and the units are detachably joined to each other by cylindrical projections 103 and 104, which fit into recesses 105 and 106.
- centre capsule unit 101/110 could have a recess at each end for receiving projections associated with the end capsule units or could have a projection at each end for insertion into recesses which would be associated with the end units.
- the capsule shown in Figure 17 is depicted in assembled form.
- inventions shown in Figures 13 to 20 may be particularly advantageous in that the divisible capsule can be easily separated by a pulling or twisting motion without the necessity of breaking or tearing a part of the capsule.
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Medicinal Preparation (AREA)
- Materials For Medical Uses (AREA)
- Developing Agents For Electrophotography (AREA)
- Electrochromic Elements, Electrophoresis, Or Variable Reflection Or Absorption Elements (AREA)
Abstract
Description
- The present invention is directed to capsules which are divisible by the user into accurate individual dosage units.
- It is desirable for a patient to be able to administer medicine to him or herself in varying dosages. Thus, a patient may begin medication in larger dosages, and then proceed to smaller dosages, or vice versa, as treatment progresses. Also, different dosages may be desirable for different individuals. Some drugs require monitoring of drug blood level until the patient is stabilized and divisible dosage forms provide a non-complicated procedure for achieving this.
- In the case of tablets, the need for variable dose administration is easily met, since tablets are breakable into smaller units and sometimes may be scored to facilitate breaking into accurate dosage units.
- In the case of a capsule however, breaking or division is not ordinarily possible without destroying the integrity of the capsule and losing some or all of the contents.
- While providing capsules in varying sizes is possible, it may not be feasible to predict in advance how many capsules in which sizes are necessary for a given patient. In addition, production of capsules in varying sizes complicates the manufacturing process and adds to the patients' cost in the event the dosage must be changed.
- Additionally, divisible capsules are desirable since they may be used to separate drugs which are interactive, for example, propoxyphene in its hydrochloride or other suitable salt form and aspirin or sodium meclofenamate and codeine sulphate. Further, they may be arranged so as to formulate a portion of the capsule to be slow releasing while the other portion furnishes drug in a readily available fast-dissolving form, or to include two or three sections all having modified release properties which will afford optimal drug blood levels or by attaching a separate section which has enteric properties.
- While divisible capsules are known in the prior art, it is believed that the capsules provided by the present invention afford advantages not heretofore realized.
- EP-A-0 141 397 discloses a divisible capsule which when undivided is in the shape of a conventional capsule. The capsule is divisible along a plane running along the entire length of the capsule and bisecting it by twisting the two "half capsule" parts away from each other. The result is two capsule units, each of which has a cross-section in the shape of a semi-circle and a flat, planar surface which previously had been connected to the flat, planar surface of the other capsule unit.
- The disadvantage of this configuration is that the unfamiliar shape of the "half-capsule", which includes a flat surface, may be unpalatable for the patient to swallow. Additionally, due to the unusual shape of each capsule unit, it is not possible to use conventional capsule filling equipment to fill the capsule units with medicine.
- US-A-1510260 discloses a package containing a plurality of gelatinuous hollow bodies, each having a rounded, closed end and, an open end, the hollow bodies being nested in series, with the last body of the series being sealed by a closure member.
- GB-A-2,148,841 discloses divisible capsules which are formed with integrally molded connection elements. For example, a number of capsule bodies would be manufactured with integrally molded webs between and connecting adjacent capsule bodies, while the capsule caps might also have such integrally molded connection elements.
- The disadvantage of this arrangement is that conventional capsule bodies and caps cannot be used, and the need for integrally moulded interconnection elements considerably complicates manufacture.
- It is thus an object of the present invention to provide a divisible capsule which separates into capsule units which are of familiar and palatable shape.
- It is a further object of the present invention to provide a divisible capsule which may utilize conventional capsule bodies or caps.
- It is still a further object of the invention to provide a divisible capsule which is relatively easy and straightforward to manufacture and which permits the use of conventional capsule filling equipment.
- According to the present invention there is provided a capsule which is divisible by the user into accurate individual dosage units, comprising at least two dosage units, each of which is capable of holding a desired medicinal preparation, and is of substantially cylindrical shape, the dosage units being detachably joined to one another in such a manner that their respective longitudinal axes are approximately co-linear in the assembled capsule, wherein each said individual dosage unit is sealed by a closure.
- If such a divisible capsule has two dosage units, the above objects are accomplished by providing a divisible capsule which is comprised of first and second dosage units, each of which is cylindrical about an axis along the major part of its length, and wherein the capsule units are detachable joined to each other in such manner that the longitudinal axes of the respective capsule units are approximately co-linear.
- Preferably at least two of the dosage units of the divisible capsule are terminal dosage units each of which has a first closed, preferably rounded end, and a second open end being sealed by a closure, and wherein each of the closures abuts the neighbouring dosage unit to which it is detachably joined in the assembled capsule. The divisible capsule may further include at least one intermediate dosage units having two open ends both of which are sealed by a closure and wherein each of the closures of the intermediate dosage unit abuts the closure of the neighbouring dosage unit, to which the intermediate dosage unit is detachably joined in the assembled capsule.
- As used herein, the term "cylindrical" encompasses tubular shapes having circular cross-sections such as elliptical cylinders. While a circular cylindrical shape is preferred, substantially cylindrical capsules of other shapes are contemplated. Thus, those having octagonal, hexagonal, square, or other geometrical cross sections are operable. Capsule shapes which resemble tablets (i.e., which are not significantly elongated) could also be used.
- The capsule units are detachably joined to each other by various expedients including connection by adhesive, an annular band, and mechanical locking means. Such an annular band may further comprise constructive regions and/or perforations.
- The invention will be better appreciated by referring to the accompanying drawings in which:
- Figures 1-4 are illustrations of a divisible capsule in accordance with several embodiments of the invention.
- Figures 5-7 illustrate a method of making the divisible capsules of the invention
- Figure 8 relates to a method of making the embodiment of Figure 3.
- Figure 9 illustrates the assembly of a divisible capsule in accordance with a further embodiment of the invention.
- Figure 10 illustrates the divisible capsule shown in Figure 9 as assembled.
- Figure 11 shows the assembly of a divisible capsule in accordance with still a further embodiment of the invention.
- Figure 12 shows the divisible capsule of Figure 11 as assembled.
- Figure 13 shows the assembly of a divisible capsule in accordance with still a further embodiment of the invention.
- Figure 14 shows the embodiment of Figure 13 as assembled.
- Figure 15 shows the assembly of a divisible capsule in accordance with still a further embodiment of the invention.
- Figure 16 shows the divisible capsule of Figure 15 as assembled.
- Figure 17 shows the assembly of a divisible capsule which is comprised of three units.
- Figure 18 shows the divisible capsule of Figure 17 as assembled.
- Figure 19 shows the assembly of a divisible capsule wherein the units are of different diameters.
- Figure 20 shows the capsule of Figure 19 as assembled.
- Referring to Figure 1,
divisible capsule 2 is shown. It is comprised ofcapsule units medicinal preparation 8. - The overall shape of
capsule 2 is similar to that of a conventional capsule. That is, each of thecapsule units - The capsule units are juxtaposed longitudinally so that the cylindrical axes of the respective capsule units are approximately co-linear and are detachably secured to each other in this configuration.
- The capsule units are secured by an adhesive and/or an annular band. In the embodiment of Figure 1,
band 10 is provided which is a thin plastic band of the type sometimes used to secure the bodies and caps of conventional capsules together. The band is perforated at 13 to permit easy separation of the capsule units from each other. - In the embodiment of Figure 2, the band is an
annular sleeve 12 havingconstrictive segments 14 to provide a friction fit. For example, the constrictive segments may be dimples or other raised areas. - The capsules depicted in Figures 1 and 2 may be taken as shown to provide a full dose or may be separated from each other by the user to provide a convenient half dose.
- It should be noted that while the capsules shown in the illustrative embodiments are bisectable capsules which provide accurate half doses, if desired, the capsules may be dividable in some other proportion, for example, one-third to two-thirds. Conceivably, the capsule could be a series of segments held together as shown and used for dose titration purposes.
- A method of making the divisible capsules is shown in Figures 5-7. In general a method of making capsules according to the present invention comprises the steps of:
filling at least two substantially cylindrical dosage units with a desired medicinal preparation;
sealing each of the dosage units with a closure; and
detachably joining the dosage units to each other in such a manner that their respective longitudinal axes are approximately co-linear. - Referring to Figure 5,
capsule units - Referring to Figure 6, the capsule units are filled with a desired medicinal preparation. This, for example, may be in the form of pellets, granules, or viscous or liquid substance. Additionally, the filling step may be performed with the automatic filling machines customarily used to fill conventional capsules.
- The capsule units would be filled to within a small distance of the top, for example about one-sixteenth of an inch, and as shown in Figure 7, a thin layer 9 of adhesive paste would be applied to the top to seal in the medicinal preparation.
- The capsule units would then be turned inwardly towards each other with the adhesive paste layers abutting each other, and adhesive paste would be applied to the inside and outside of the joint area, after which the joint would be air dried.
- After this, a band or sleeve as shown in Figures 1 and 2 would be added.
-
- Further embodiments of the divisible capsule of the invention are shown in Figures 3 and 4. In these embodiments, the capsule units are as shown in Figure 8, and each comprises a body portion (22, 24) and a cap (26, 28), wherein the cap (26, 28 ) has a flat surface and is fitted to snugly fit over the body portion (22, 24).
- The caps (26, 28) are bonded to each other with
adhesive paste 30 as shown in Figure 3 or by a separately molded section which is sealed to the capsule section by means of solvent welding. - In the embodiment shown in Figure 4, a
band 31 havingconstrictive segments 32 is also added. It is possible that in this embodiment one may dispense with the adhesive paste. - Figures 9-16 illustrate further embodiments of the invention wherein locking mechanical means is used to join the two capsule units.
- Referring to Figure 9,
capsule units medicinal preparation 46.Capsule unit 40 is enclosed bycap 42 whilecapsule unit 44 is closed byadhesive layer 48 or by a friction fit with or without use of a solvent seal. - Intermediate molded locking
part 50 is used to secure the two capsule units together. Lockingpart 50 has opencylindrical recess 53 andannular groove 55.Cap 42 ofcapsule unit 40 is held snugly inannular groove 55. The molded piece may be made of the same material as the capsule units and the divisible capsule as assembled is shown in Figure 10. - Referring to the embodiment of Figure 11,
capsule unit 51 is closed bycap 52 and intermediate moldedpiece 56 serves both as a closure forcapsule unit 54 and as a connecting means to secure the two capsule units together. - Molded
piece 56 has opencylindrical recesses Recess 57 is sized so as to snugly receivecap 52 ofcapsule unit 51 whilerecess 59 is sized so as to receivecapsule unit 54 in such manner that flat surface 61 acts as a closure for the medicinal preparation incapsule unit 54. - Additionally, the
recesses - A further embodiment to the invention is shown in Figure 13 wherein cylindrical
capsule unit parts 60 and 64 are shown. Each of these capsule unit parts is filled with a desired medicinal preparation, and the capsule unit parts are sealed with rounded orflat caps female member 68 which may for example be a cylindrical recess, whilecapsule unit 64 is provided with amale member 70, which for example may be a cylindrical projection resembling a spike. The male and female members are sized so as to provide a tight friction fit, which may be enhanced by the provision of additional locking means such as one or more dimples on one of the members and a corresponding number of detents on the other of the members.Capsule unit parts 60 and 64 may be made of hard gelatin or other known material used for capsule bodies. The assembled divisible capsule is shown at Figure 14. - Figures 15 and 16 illustrate a divisible capsule which is similar to that shown in Figures 13 and 14, except that the locking recess and projection are larger in diameter.
- Figure 17 illustrates a divisible capsule which is comprised of three units instead of two. The units are
body 100/cap 107,body 102/cap 108, andbody 101/cap 110. As shown,cap 110 has acylindrical recess 106 therein, and the units are detachably joined to each other bycylindrical projections 103 and 104, which fit intorecesses centre capsule unit 101/110 could have a recess at each end for receiving projections associated with the end capsule units or could have a projection at each end for insertion into recesses which would be associated with the end units. In Figure 18, the capsule shown in Figure 17 is depicted in assembled form. - The embodiment illustrated in Figures 19 and 20 is similar to the embodiment of Figures 15 and 16, except that one of the capsule units is of greater diameter that the other.
- The embodiments shown in Figures 13 to 20 may be particularly advantageous in that the divisible capsule can be easily separated by a pulling or twisting motion without the necessity of breaking or tearing a part of the capsule.
Claims (14)
- A capsule which is divisible by the user into accurate individual dosage units, comprising at least two dosage units, each of which is capable of holding a desired medicinal preparation, and is of substantially cylindrical shape, the dosage units being detachably joined to one another in such a manner that their respective longitudinal axes are approximately co-linear in the assembled capsule, characterised in that each said individual dosage unit is sealed by a closure.
- A divisible capsule according to claim 1, wherein two of the at least two dosage units are terminal dosage units, each of which has a first closed, preferably rounded end, and a second open end which is sealed by a closure, and wherein each of the closures abuts the neighbouring dosage unit to which it is detachably joined in the assembled capsule.
- A divisible capsule according to claim 2, further provided with at least one intermediate dosage unit having two open ends, both of which are sealed by a closure, and wherein each of the closures of the intermediate dosage unit abuts the closure of the neighbouring dosage units, to which the intermediate dosage unit is detachably joined in the assembled capsule.
- A divisible capsule according to claim 1, 2 or 3, wherein the dosage units are joined together by adhesive.
- A divisible capsule according to any preceding claim, wherein the dosage units are joined together by an annular band.
- A divisible capsule according to claim 5, wherein the annular band has constrictive regions or perforations.
- A divisible capsule according to any preceding claim, wherein the dosage units are detachably joined together by mechanical locking means.
- A divisible capsule according to claim 7, wherein the mechanical locking means includes a hollow cylindrical member open at one end in which it is capable of accommodating a dosage unit.
- A divisible capsule according to claim 8, wherein the hollow cylindrical member is further provided with a planar member which acts as a closure for sealing a further dosage unit in the assembled capsule.
- A divisible capsule according to claim 7, wherein the mechanical locking means comprises interlocking male and female members respectively provided on neighbouring ends of the dosage units as assembled.
- A divisible capsule according to claim 10, wherein the male member includes a projection and the female includes a recess.
- A divisible capsule according to claim 10 or 11, wherein the male and female members have a friction fit when interlocked.
- A divisible capsule according to any preceding claim, wherein the closure is in the form of a cap.
- A method of making a capsule according to any one of claims 1 to 13, which method comprises the steps of:
filling at least two substantially cylindrical dosage units with a desired medicinal preparation;
sealing each of the dosage units with a closure; and
detachably joining the dosage units to each other in such a manner that their respective longitudinal axes are approximately co-linear.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AT87810649T ATE65907T1 (en) | 1986-11-13 | 1987-11-10 | DIVIDEABLE CAPSULE. |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US93060186A | 1986-11-13 | 1986-11-13 | |
US930601 | 1986-11-13 |
Publications (2)
Publication Number | Publication Date |
---|---|
EP0274345A1 EP0274345A1 (en) | 1988-07-13 |
EP0274345B1 true EP0274345B1 (en) | 1991-08-07 |
Family
ID=25459506
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP87810649A Revoked EP0274345B1 (en) | 1986-11-13 | 1987-11-10 | Dividable capsule |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP0274345B1 (en) |
JP (1) | JPS63135174A (en) |
KR (1) | KR880005915A (en) |
AT (1) | ATE65907T1 (en) |
AU (1) | AU603614B2 (en) |
BR (1) | BR8706068A (en) |
DE (1) | DE3772023D1 (en) |
ES (1) | ES2023943B3 (en) |
GR (1) | GR3002447T3 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9223172D0 (en) * | 1992-11-05 | 1992-12-16 | Scherer Corp R P | Capsule construction |
GB9223144D0 (en) * | 1992-11-05 | 1992-12-16 | Scherer Corp R P | Controlled release device |
JP2606177B2 (en) * | 1995-04-26 | 1997-04-30 | 日本電気株式会社 | Printed wiring board |
CZ2002336A3 (en) | 1999-07-30 | 2002-06-12 | Smithkline Beecham Plc | Multicomponent pharmaceutical dosage form |
CA2625776A1 (en) * | 2005-10-14 | 2007-04-26 | Microdose Technologies, Inc. | Pharmaceutical packaging of an oral dosage combination |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0191438A2 (en) * | 1985-02-11 | 1986-08-20 | Klinge Pharma GmbH | Double capsule for receiving medicines |
EP0225565B1 (en) * | 1985-12-06 | 1991-05-08 | Boehringer Ingelheim Kg | Divisible capsule |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1510260A (en) * | 1921-06-30 | 1924-09-30 | Lloyd W Cyrenius | Capsule |
GB746782A (en) * | 1953-09-18 | 1956-03-21 | Charles Brown | Improvements in or relating to machines for sealing gelatine or the like capsules |
US2762411A (en) * | 1954-12-07 | 1956-09-11 | Hardfield Corp | Containers of capsule-like form |
CH485464A (en) * | 1965-04-15 | 1970-02-15 | Glassman Jacob A | Process for the production of a longitudinally H-shaped gelatin composite sleeve |
-
1987
- 1987-10-29 AU AU80505/87A patent/AU603614B2/en not_active Ceased
- 1987-11-10 EP EP87810649A patent/EP0274345B1/en not_active Revoked
- 1987-11-10 BR BR8706068A patent/BR8706068A/en unknown
- 1987-11-10 ES ES87810649T patent/ES2023943B3/en not_active Expired - Lifetime
- 1987-11-10 DE DE8787810649T patent/DE3772023D1/en not_active Revoked
- 1987-11-10 AT AT87810649T patent/ATE65907T1/en not_active IP Right Cessation
- 1987-11-11 KR KR870012685A patent/KR880005915A/en not_active Application Discontinuation
- 1987-11-12 JP JP62284410A patent/JPS63135174A/en active Pending
-
1991
- 1991-08-08 GR GR91401041T patent/GR3002447T3/en unknown
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0191438A2 (en) * | 1985-02-11 | 1986-08-20 | Klinge Pharma GmbH | Double capsule for receiving medicines |
EP0225565B1 (en) * | 1985-12-06 | 1991-05-08 | Boehringer Ingelheim Kg | Divisible capsule |
Also Published As
Publication number | Publication date |
---|---|
JPS63135174A (en) | 1988-06-07 |
BR8706068A (en) | 1988-06-21 |
EP0274345A1 (en) | 1988-07-13 |
AU603614B2 (en) | 1990-11-22 |
GR3002447T3 (en) | 1992-12-30 |
ES2023943B3 (en) | 1992-02-16 |
AU8050587A (en) | 1988-05-19 |
KR880005915A (en) | 1988-07-21 |
ATE65907T1 (en) | 1991-08-15 |
DE3772023D1 (en) | 1991-09-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5074426A (en) | Dividable capsule | |
US5415868A (en) | Caplets with gelatin cover and process for making same | |
US4928840A (en) | Tamper proof encapsulated medicaments | |
US4800083A (en) | Sustained release method and product | |
CA2193248C (en) | Caplet and gelatin covering therefor | |
US5464631A (en) | Encapsulated dosage forms | |
US7641916B2 (en) | Digestible and volume adjustable multi medication delivery device | |
JPH0561942B2 (en) | ||
BRPI0711086A2 (en) | multi-chamber container and method for opening the same | |
GB2148841A (en) | Capsulated medicaments | |
KR840005662A (en) | Manufacturing method of analgesic capsule | |
US20050055013A1 (en) | Medication delivery device | |
JP2011500185A (en) | Linker for multipart dosage form for releasing one or more pharmaceutical compositions, and the resulting dosage form | |
US7622137B2 (en) | Dosage forms contained within a capsule or sachet | |
EP0274345B1 (en) | Dividable capsule | |
US5873860A (en) | Injection device | |
CA1045547A (en) | Capsule, especially for medicaments | |
JPS62133960A (en) | Separable capsule and its production | |
KR101870818B1 (en) | Oriental Medicine pill and method for manufacturing the same | |
US3990455A (en) | Teether | |
CN215308381U (en) | Intracardiac branch of academic or vocational study first aid medicine packing plant | |
KR20190077096A (en) | Multiple charge / chamber soft gel die | |
US20090162430A1 (en) | Gelatin Capsule With Extra Cap for Combined Therapies | |
EP0303640A1 (en) | Tamper evident capsule and insert device | |
CN219251008U (en) | Inner slow-release structure of slow-release hollow capsule |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 19871112 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH DE ES FR GB GR IT LI LU NL SE |
|
17Q | First examination report despatched |
Effective date: 19891208 |
|
ITF | It: translation for a ep patent filed |
Owner name: BARZANO' E ZANARDO ROMA S.P.A. |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AT BE CH DE ES FR GB GR IT LI LU NL SE |
|
REF | Corresponds to: |
Ref document number: 65907 Country of ref document: AT Date of ref document: 19910815 Kind code of ref document: T |
|
ET | Fr: translation filed | ||
REF | Corresponds to: |
Ref document number: 3772023 Country of ref document: DE Date of ref document: 19910912 |
|
REG | Reference to a national code |
Ref country code: ES Ref legal event code: FG2A Ref document number: 2023943 Country of ref document: ES Kind code of ref document: B3 |
|
PLBI | Opposition filed |
Free format text: ORIGINAL CODE: 0009260 |
|
26 | Opposition filed |
Opponent name: BOEHRINGER INGELHEIM GMBH -ABTEILUNG PATENTE- Effective date: 19920505 |
|
NLR1 | Nl: opposition has been filed with the epo |
Opponent name: BOEHRINGER INGELHEIM GMBH |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GR Payment date: 19930929 Year of fee payment: 7 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: LU Payment date: 19931001 Year of fee payment: 7 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 19931011 Year of fee payment: 7 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: AT Payment date: 19931015 Year of fee payment: 7 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: SE Payment date: 19931025 Year of fee payment: 7 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: FR Payment date: 19931110 Year of fee payment: 7 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: ES Payment date: 19931118 Year of fee payment: 7 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DE Payment date: 19931126 Year of fee payment: 7 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: NL Payment date: 19931130 Year of fee payment: 7 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: BE Payment date: 19931210 Year of fee payment: 7 |
|
EPTA | Lu: last paid annual fee | ||
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: CH Payment date: 19931217 Year of fee payment: 7 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 19941110 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: ES Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 19941111 |
|
EAL | Se: european patent in force in sweden |
Ref document number: 87810649.1 |
|
RDAG | Patent revoked |
Free format text: ORIGINAL CODE: 0009271 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: PATENT REVOKED |
|
27W | Patent revoked |
Effective date: 19950109 |
|
GBPR | Gb: patent revoked under art. 102 of the ep convention designating the uk as contracting state |
Free format text: 950109 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
NLR2 | Nl: decision of opposition | ||
REG | Reference to a national code |
Ref country code: GR Ref legal event code: MF4A Free format text: 3002447 |